Calcium fructoborate helps control inflammation associated with diminished bone health

Biological Trace Element Research

Volumn 155, Issue 3, 2013, Pages 315-321

  Scorei, Iulia Daria ^a   Scorei, Romulus Ion ^b  

^a Bioboron Research Institute   (Romania)

^b UNIVERSITY OF CRAIOVA   (Romania)

Author keywords

Bone health; Boron; Fructoborate; Inflammation

Indexed keywords

AQUAPORIN; ARACHIDONIC ACID; BIOLOGICAL MARKER; BORON; C REACTIVE PROTEIN; CALCIUM DERIVATIVE; CALCIUM FRUCTOBORIC ACID; COLECALCIFEROL; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOACCUMULATION; BONE DENSITY; BONE DISEASE; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DOWN REGULATION; FRUIT VEGETABLE; HUMAN; NONHUMAN; OSTEOLYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; THERAPY EFFECT; VITAMIN D DEFICIENCY;

ANTI-INFLAMMATORY AGENTS; BONE AND BONES; BONE DISEASES; BORATES; C-REACTIVE PROTEIN; CALCIUM, DIETARY; DIETARY SUPPLEMENTS; FRUCTOSE; HUMANS; INFLAMMATION;

EID: 84888191577     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-013-9800-y     Document Type: Article

References (69)

1. Dembitsky VM, Smoum R, Al-Quntar AAA, Ali HA, Pergament I, Srebnik M (2009) Natural occurrence of boron-containing compounds in plants, algae and microorganisms. Plant Sci 163:931-942
2. Ishii T, Matsunaga T (1996) Isolation and characterization of a boron-rhamnogalacturonan-II complex from cell walls of sugar beet pulp. Carbohydr Res 284:1-9
3. Matsunaga I, Ishi T, Watanbe H (1996) Speciation of water-soluble boron compounds in radish roots by size exclusion HPLC/ICP-MS. Anal Sci 12:673-675
4. 11B NMR observation of plant tissue. Anal Sci 11:889-892
5. Hunt CD (2012) Dietary boron: progress in establishing essential roles in human physiology. J Trace Elem Exp Biol 26:157-160
6. Goldbach HE, Huang L, Wimmer MA (2007) Boron functions in plants and animals: recent advances in boron research and open questions. In: Xu F, Goldbach HE, Brown PH et al (eds) Advances in plant and animal boron nutrition. Springer, Dordrecht, pp 3-25
7. Nielsen FH (2008) Is boron nutritionally relevant? Nutr Rev 66(4):183-191
8. Nielsen F, Meacham S (2011) Growing evidence for human health benefits of boron. J Evid Based Complement Alternat Med 16:3169-3180
9. Hunt CD, Idso JP (1999) Dietary boron as a physiological regulator of the normal inflammatory response: a review and current research progress. J Trace Elem Exp Biol 12:221-233
10. Hunt CD (2003) Dietary boron: an overview of the evidence for its role in immune function. J Trace Elem Exp Biol 16:291-306
11. 3 nutriture on indices of energy substrate utilization and mineral metabolism in the chick. J Bone Miner Res 9:171-181
12. Scorei RI, Rotaru P (2011) Calcium fructoborate - potential anti-inflammatory agent. Biol Trace Elem Res 143(3):1223-1238
13. Wagner CC, Ferraresi Curotto V, Pis Diez R, Baran EJ (2008) Experimental and theoretical studies of calcium fructoborate. Biol Trace Elem Res 122:64-72
14. Miljkovic D, Scorei IR, Cimpoiasu VM, Scorei ID (2009) Calcium fructoborate: plant based dietary boron for human nutrition. J Diet Suppl 6:211-226
15. Rotaru P, Scorei R, Harabor A, Dumitru MD (2010) Thermal analysis of a calcium fructoborate sample. Thermochim Acta 506:8-13
16. Scorei R, Ciubar R, Iancu C, Mitran V, Cimpean A, Iordachescu D (2007) In vitro effects of calcium fructoborate on fMLP-stimulated human neutrophil granulocytes. Biol Trace Elem Res 118:27-37
17. Scorei RI, Ciofrangeanu C, Ion R et al (2010) In vitro effects of calcium fructoborate upon production of inflammatory mediators by LPS-stimulated RAW 264.7 macrophages. Biol Trace Elem Res 135:334-344
18. Scorei R, Mitrut P, Petrisor I, Scorei ID (2011) A double-blind, placebo-controlled pilot study to evaluate the effect of calcium fructoborate on systemic inflammation and dyslipidemia markers for middle-aged people with primary osteoarthritis. Biol Trace Elem Res 144(1-3):253-263
19. Reyes-Izquierdo T, Nemzer B, Gonzalez AE, Zhou Q, Argumedo R, Shu C, Pietrzkowski ZB (2012) Short-term intake of calcium fructoborate improves WOMAC and McGill scores and beneficially modulates biomarkers associated with knee osteoarthritis: a pilot clinical double-blinded placebo-controlled study. J Biomed Sci 4(2):111-122
20. Militaru C, Donoiu I, Craciun A, Scorei ID, Bulearca AM, Scorei RI (2013) Oral resveratrol and calcium fructoborate supplementation in subjects with stable angina pectoris: effects on lipid profiles, inflammation markers, and quality of life. Nutrition 29(1):178-183
21. Du Clos TW (2000) Function of C-reactive protein. Ann Med 32(4):274-278
22. Dehghan A, Kardys I, de Maat MP, Uitterlinden AG, Sijbrands EJ, Bootsma AH, Stijnen T, Hofman A, Schram MT, Witteman JC (2007) Genetic variation, C-reactive protein levels, and incidence of diabetes. Diabetes 56(3):872-878
23. Ridker PM (2003) Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107:363-369
24. Devaraj S, Singh U, Jialal I (2009) Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol 20(3):182-189
25. Smith JW, Martins TB, Gopez E, Johnson T, Hill HR, Rosenberg TD (2012) Significance of C-reactive protein in osteoarthritis and total knee arthroplasty outcomes. Ther Adv Musculoskelet Dis 4(5):315-325
26. Devlin J, Gough A, Huissoon A, Perkins P, Holder R, Reece R, Arthur V, Emery P (1997) The acute phase and function in early rheumatoid arthritis. C-reactive protein levels correlate with functional outcome. J Rheumatol 24(1):9-13
27. Koh J-M, Khang Y-H, Jung C-H, Bae S, Kim DJ, Chung Y-E Kim GS (2005) Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporos Int 16:1263-1271
28. De Pablo P, Cooper MS, Buckley CD (2012) Association between bone mineral density and C-reactive protein in a large population-based sample. Arthritis Rheum 64(8):2624-2631
29. Tanaka Y, Nakayamada S, Okada Y (2005) Osteoblasts and osteoclasts in bone remodeling and inflammation. Curr Drug Targets Inflamm Allergy 4(3):325-328
30. Thmson BM, Mundy GR, Chambers TJ (1987) Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immun 138:775-779
31. Hardy R, Cooper MS (2009) Bone loss in inflammatory disorders. J Endocrinol 201:309-320
32. Stobaugh DJ, Deepak P, Ehrenpreis ED (2013) Increased risk of osteoporosis-related fractures in patients with irritable bowel syndrome. Osteoporos Int 24(4):1169-1175
33. Weitzmann MN, Pacifici R (2006) Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest 116(5):1186-1194
34. Manda D, Popa O, Vladoiu S, Dumitrache C (2009) Calcium fructoborate effect on osteoblast mineralization in vitro. Bone 44(2):S298-S299
35. Dinca L, Scorei R (2013) Boron in human nutrition and its regulations use. J Nutr Ther 2(1):22-28
36. Goldring SR (2003) Bone loss in chronic inflammatory conditions. J Musculoskel Neuron Interact 3(4):287-289
37. Goldring SR, Gravallese EM (2000) Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications. Arthritis Res 2:33-37
38. Gough AK, Lilley J, Eyre S, Holder RL, Emery P (1994) Generalised bone loss in patients with early rheumatoid arthritis. Lancet 344:23-27
39. Spector TD, Hall GM, McCloskey EV, Kanis JA (1993) Risk of vertebral fracture in women with rheumatoid arthritis. Br Med J 306:558
40. Schoon EJ, Blok BM, Geerling BJ, Russel MG, Stockbrugger RW, Brummer RJ (2000) Bone mineral density in patients with recently diagnosed inflammatory bowel disease. Gastroenterology 119:1203-1208
41. Bultink IE, Lems WF, Kostense PJ, Dijkmans BA, Voskuyl AE (2005) Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 52:2044-2050
42. Mantovani A, Garlanda C, Doni A, Bottazzi B (2008) Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3. J Clin Immunol 28:1-13
43. Koukkunen H, Penttilä K, Kemppainen A, Halinen M, Penttila I, Rantanen T, Pyörälä K (2001) C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris. Ann Med 33(1):37-47
44. Thomson BM, Mundy GR, Chambers TJ (1987) Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol 138:775-779
45. Ginaldi L, Di Benedetto MC, De Martinis M (2005) Osteoporosis, inflammation and ageing. Immun Ageing 2:14. doi: 10.1186/1742-4933-2-14
46. Rifai N, Ridker PM (2001) High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem 47(3):403-411
47. Attur M, Krasnokutsky-Samuels S, Samuels S, Abramson SB (2013) Prognostic biomarkers in osteoarthritis. Curr Opin Rheumatol 25:136-144
48. Kim BJ, Yu YM, Kim EN, Chung YE, Koh JM, Kim GS (2007) Relationship between serum hsCRP concentration and biochemical bone turnover markers in healthy pre- and postmenopausal women. Clin Endocrinol (Oxf) 67(1):152-158
49. Hafez EA, Mansour HE, Hamza SH, Moftah SG, Younes TB, Ismail MA (2011) Bone mineral density changes in patients with recent-onset rheumatoid arthritis. Clin Med Insights Arthritis Musculoskelet Disord 4:87-94
50. Benhamou M, Gossec L, Dougados M (2010) Clinical relevance of C-reactive protein in ankylosing spondylitis and evaluation of the NSAIDs/coxibs' treatment effect on C-reactive protein. Rheumatol 49(3):536-541
51. Handa R (2003) Approach seronegative arthritis. JIACM 4(3):190-192
52. Filipowicz R, Greene T, Wei G, Cheung AK, Raphael KL, Baird BC, Beddhu S (2013) Associations of serum skeletal alkaline phosphatase with elevated C-reactive protein and mortality. Clin J Am Soc Nephrol 8(1):26-32
53. El-Maouche D, Xu X, Cofrancesco J, Adrian S, Dobs AS, Brown TT (2011) Prevalence of low bone mineral density in a low-income inner-city population. J Bone Miner Res 26(2):388-396
54. Scorei R (2011) Boron compounds in the breast cancer cells. Chemoprevention and chemotherapy. In: Gunduz E, Gunduz M (eds) Breast cancer - current and alternative therapeutic modalities. InTech, Rijeka, pp 92-114
55. Scorei RI, Popa R (2013) Sugar-borate esters - potential chemical agents in prostate cancer chemoprevention. AntiCancer Agents Med Chem 13(6):901-909
56. Scorei R (2013) Regulation of therapeutic potential of boron-containing compounds. In: Kretsinger RH, Uversky VN, Permyakov EA (eds) Encyclopedia of metalloproteins, 1st edn. Springer, Berlin, p 100
57. Hu H, Penn S, Lebrillo C, Brown PH (1997) Isolation and characterization of soluble boron complexes in higher plants. Plant Physiol 113:649-55
58. Criste RD, Grossu DV, Scorei R et al. (2005) New investigations on the effect of the dietary boron on broilers and layers: boron and food quality. Arch Zoot 8:65-78. [Available at http://www.ibna.ro/arhiva/AZ%208/AZ%208- 06%20RCriste.pdf ] Accessed 26 April 2013
59. Taranu I, Marin DE, Manda G, Motiu M, Neagoe I, Tabuc C, Stancu M, Olteanu M (2011) Assessment of the potential of a boron-fructose additive in counteracting the toxic effect of Fusarium mycotoxins. Br J Nutr 106(3):398-407
60. Dessein PH, Stanwix AE, Joffe BJ (2002) Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis. Arthritis Res 4:R5
61. Ghivercea V, Grecu D, Lichiardopol C, Maria R (2004) Tratamentul osteoporozei cu fructoborat de calciu. Revista de Ortopedie si Traumatologie (Bucuresti) 14(1-2):75-82
62. Scorei R, Cimpoiasu VM, Iordachescu D (2005) In vitro evaluation of the antioxidant activity of calcium fructoborate. Biol Trace Elem Res 107:127-134
63. Park M, Li Q, Shcheynikov N, Zeng W, Muallem S (2004) NaBC1 is a ubiquitous electrogenic Na+-coupled borate transporter essential for cellular boron homeostasis and cell growth and proliferation. Mol Cell 16:331-341
64. Scorei R, Ciubar R, Ciofrangeanu CM, Mitran V, Cimpean A, Iordachescu D (2008) Comparative effects of boric acid and calcium fructoborate on breast cancer cells. Biol Trace Elem Res 122:197-205
65. Bienert GP, Chaumont F (2013) Aquaporins and boron. In: Kretsinger RH, Uversky VN, Permyakov EA (eds) Encyclopedia of metalloproteins, 1st edn. Springer, Berlin, p 100
66. Scorei R (2012) Is boron a prebiotic element? A mini-review of the essentiality of boron for the appearance of life on Earth. Orig Life Evol Biosph 42(1):3-17
67. Bassil E, Hu H, Brown PH (2004) Use of phenylboronic acids to investigate boron function in plants. Possible role of boron in transvacuolar cytoplasmic strands and cell-to-wall adhesion. Plant Physiol 136(2):3383-5
68. Hunt CD (2002) Boron-binding biomolecules: a key to understanding the beneficial physiologic effects of dietary boron from prokaryotes to humans. In: Goldbach HE, Rerkasem B, Wimmer MA, Brown PH, Thellier M, Bell RW (eds) Boron in plant and animal nutrition. Kluwer, New York, pp 21-36
69. Meacham S, Karakas S, Wallace A, Altun F (2010) Boron in human health: evidence for dietary recommendations and public policies. Open Miner Process J 3:36-53